Test Price
2,800 AEDโ Home Collection Available
MYH7 Gene Scapuloperoneal Myopathy Genetic Test in the UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity โ our NGS testing is processed in an ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited facility, ensuring results you can trust.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy, available daily from 8 AM to 11 PM. Acceptable specimens: Whole blood, extracted DNA, or dried blood spot (FTA card).
Clinical Oversight: Telephonic Post-Test Clinical Guidance for result interpretation and integrated genetic counselling provided directly by our DHA-licensed Consultant Medical Geneticist.
Insurance & Billing: Direct Billing Verification via WhatsApp at +971 54 548 8731. We handle the administrative paperwork.
Test Overview & Methodology
This advanced next-generation sequencing (NGS) test analyzes the entire MYH7 gene to detect pathogenic variants causing scapuloperoneal myopathy, a rare neuromuscular disorder with potential cardiac involvement. The analysis covers all coding exons and flanking intronic regions, providing a definitive molecular diagnosis.
| Feature | Our Test (MYH7 NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity; detects single nucleotide variants, indels, and copy number changes | >99% for single targets but misses large rearrangements and mosaic mutations |
| Methodology | Next-Generation Sequencing (NGS) โ Gold standard for comprehensive genetic analysis | Sanger sequencing โ limited to small targeted regions, higher cost per base for large genes |
| Turnaround Time | 3 to 4 Weeks | 6โ8 Weeks typical |
| Clinical Utility | Comprehensive, covering all MYH7-related phenotypes (scapuloperoneal myopathy, Emery-Dreifuss, cardiomyopathies) | Often requires sequential testing of multiple exons; higher risk of incomplete diagnosis |
Physician Insight & Safety Protocols
โAs a Consultant Medical Geneticist, I emphasize that genetic testing for MYH7 provides a definitive diagnosis but must be correlated with clinical findings, family history, and cardiac evaluations. A positive result allows for cascade testing in at-risk relatives and guides surveillance for preventable complications like cardiomyopathy. Our commitment is to provide not just a test result, but a comprehensive support system for you and your family.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication & Clinical Advisory
Important Medication Warning
Do not discontinue any prescribed medication, including heart or muscle-related therapies, without consulting your treating physician. This genetic test does not replace ongoing clinical management or emergency care.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Active febrile illness; recent blood transfusion (<3 weeks); inability to provide informed consent. Pregnancy is not a contraindication but genetic counselling is mandatory.
Emergency Red Flags
- Sudden onset of severe muscle weakness, difficulty swallowing or breathing, syncope (fainting), chest pain, or palpitationsโgo to the nearest emergency department immediately.
- This test is not for standalone decision-making; always correlate with clinical data and specialist assessment.
Patient FAQ & Clinical Guidance
1. What conditions does the MYH7 gene test detect?
This accurate DNA test identifies MYH7 mutations causing scapuloperoneal myopathy, Emery-Dreifuss dystrophy, and familial cardiomyopathy. It provides a definitive genetic diagnosis when clinical features overlap, enabling precise subtyping and tailored surveillance for cardiac involvement. The report includes pathogenicity classification based on ACMG guidelines.
2. How is the test performed and what is the sample requirement?
A simple blood draw or DNA sample is collected at home via our VIP mobile phlebotomy service and analyzed using next-generation sequencing. We accept whole blood in EDTA tubes, extracted DNA, or a single drop of blood on an FTA card. The cold-chain transport preserves sample integrity, and you receive a detailed pre-genetic counselling session to document a three-generation pedigree.
3. What do the results mean for my family members?
Positive results confirm a heritable mutation, enabling cascade testing of at-risk relatives for early intervention. If a pathogenic variant is identified, first-degree relatives have a 50% risk of carrying the same alteration, which may manifest even with mild symptoms. Our genetic counsellor will guide you through family communication strategies and facilitate testing for others under UAE PDPL-compliant consent.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Privacy
This service strictly adheres to Federal Decree-Law No. 4 of 2016 on Medical Liability and Federal Law No. 2 of 2019 concerning health data security. All genetic data is processed and stored locally under the supervision of the Dubai Health Authority (DHA), in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL). DNA Labs UAE is an ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | MYH7 Gene Scapuloperoneal Myopathy Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) โ Whole Gene Sequencing |
| ICD-10-CM Code | G71.0 (Muscular Dystrophy) |
| LOINC Code | 93928-0 (Genetic analysis) |
| DHA Facility License & Address | DHA License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians